logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
D

DIABETES OBESITY & METABOLISM

IF5.7
论文数627
被引数
期刊论文 627
发表时间
delete
Estimated sdLDL-C/LDL-C Discordance Is Associated With Advanced Cardiovascular–Kidney–Metabolic Syndrome, Incident Cardiovascular Disease and Mortality: Evidence From Two Population-Based Cohorts估算的sdLDL-C/LDL-C不匹配与进展性心血管-肾脏-代谢综合征、心血管事件发生和死亡率相关：基于两项基于人群队列研究的证据
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-28
delete0
PREAI
deleteHonglin Sun; Ruixiang Cui; Lanxuan Jiang; Jia Liu; Guang Wang
delete分享
delete收藏
α-Hydroxybutyrate and Cardiovascular Outcomes in People Living With Type 2 Diabetes: An EXSCEL Post Hoc Analysisα-羟基丁酸盐与2型糖尿病患者心血管结局：EXSCEL事后分析
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-28
delete0
deleteOAAI
deleteAfsaneh Noormandi; Faisal Aziz; Tobias Madl; Hansjörg Habisch; John B. Buse; Robert John Mentz; Abderrahim Oulhaj; Thomas R. Pieber; Svati H. Shah; Rury R. Holman; Harald Sourij
delete分享
delete收藏
Association of CT-Derived Skeletal Muscle Radiodensity and Index With Cerebral Small Vessel Disease: A Community-Based StudyCT衍生骨骼肌放射密度和指数与脑血管微小病变的关联：一项基于社区的研究
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-28
delete0
PREAI
deleteYuan Yuan; Xueli Cai; Luyan Wang; Yingying Yang; Lijie Ren; Mengxing Wang; Dingwen Zhang; Yuesong Pan; Yilong Wang
delete分享
delete收藏
Neuropsychiatric Outcomes Associated With GLP-1 Receptor Agonist Use in Medicare Beneficiaries With Type 2 Diabetes: Variation by Treatment Pattern and Obesity StatusGLP-1受体激动剂在2型糖尿病医保受益者中的神经精神结局：治疗模式和肥胖状况的影响差异
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-28
delete0
deleteOAAI
deleteSeo Hyon Baik; Fitsum Baye; Haotian Xian; Kin Wah Fung; Clement J. McDonald
delete分享
delete收藏
Impact of Semaglutide Introduction on the Use of Concomitant Medications: An Interrupted Time Series司美格鲁肽引入对联合用药使用的影响：一项中断时间序列研究
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-28
delete0
deleteOAAI
deleteNoémie Roland; Heidi Sonne; Katrine Mose; Katrine Kjærgaard; Carina Lundby; Maja Bramming; Lise Gehrt Cardél; Anton Pottegård; Helene Kildegaard
delete分享
delete收藏
Efficacy and Safety of CagriSema in Type 2 Diabetes: A Dose- and Comparator-Specific Systematic Review and Bayesian Meta-AnalysisCagriSema在2型糖尿病中的疗效与安全性：一项剂量和对照药物特异性的系统评价与贝叶斯Meta分析
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-28
delete0
deleteOAAI
deleteChia Siang Kow; Abdullah Faiz Zaihan; Dinesh Sangarran Ramachandram; Kaeshaelya Thiruchelvam
delete分享
delete收藏
Non-Albumin Proteinuria After Sequential Finerenone: Interpreting a Derived Marker顺次使用非奈利酮后的非白蛋白尿蛋白：解读衍生标志物
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-28
delete0
PREAI
deleteQinyi Yin; Hao Lu
delete分享
delete收藏
Preventive Effect of Smoking Cessation on Diabetes Onset: A Target Trial Emulation Approach戒烟对糖尿病发病的预防作用：一种目标试验模拟方法
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-28
delete0
PREAI
deleteShinta Yamamoto; Hiroshi Okada; Tomohiro Shinozaki; Kenya Kasahara; Nozomi Kuramoto; Takahiro Ichikawa; Hanako Nakajima; Yoshitaka Hashimoto; Arata Sano; Emi Ushigome; Naoko Nakanishi; Masahide Hamaguchi; Hiroaki Murata; Kazushiro Kurogi; Eri Tsuda; Naoki Yoshida; Masato Ito; Michiaki Fukui
delete分享
delete收藏
Sustained Versus Minimal GLP-1 Receptor Agonist Exposure and Metabolic Outcomes in Older Adults Without Diabetes老年2型糖尿病患者中GLP-1受体激动剂持续与最小暴露对代谢结局的影响
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-24
delete0
deleteOAAI
deleteReuven Zaritsky; Nili Elior; Talish Razi; Naama Sitry; Alexander Lustman; Sophia Eilat-Tsanani; Hadar Shahaf; Idan Barzilay; Belle Tamir-Brahms; Shani Afek; Naama Katz Hanein; Ronen Arbel; Michal Shani
delete分享
delete收藏
Plasma Proteomic Signatures for Early Risk Stratification Across Cardiovascular-Kidney-Metabolic Stages 0–2血浆蛋白质组学特征用于心血管-肾脏-代谢阶段0-2的早期风险分层
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-23
delete0
PREAI
deleteXingyu Li; Hongqiang Zhang; Suijian Wang; Jie Shi; Junhao Zhang; Minghui Chen; Minzhe Zhao; Tong Yue; Xueying Zheng
delete分享
delete收藏
Accuracy of Water Intake During Simulated Administration of Oral Semaglutide模拟口服司美格鲁肽给药期间水摄入量的准确性
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-23
delete0
PREAI
deleteNuttavadee Ketaroonrut; Methus Jantarapootirat; Sirinapa Traiwanatham; Pornalat Katekao; Chutintorn Sriphrapradang
delete分享
delete收藏
GLP-1 Receptor Agonist Therapy Is Associated With Lower Risk of Lower Extremity Amputation in Adults With Type 2 Diabetes and Foot Ulcer Without Coded Peripheral Arterial Disease: A Hypothesis-Generating Real-World Cohort Study胰高血糖素样肽-1受体激动剂疗法与2型糖尿病合并足部溃疡但无编码外周动脉疾病成年患者下肢截肢风险降低相关：一项产生假说的真实世界队列研究
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-23
delete0
deleteOAAI
deleteHani Robinson; Mustafa Yassin; Dror Robinson; Mohamad Eisa; Waseem Abu Rashed; Feras Qawasmi; Assil Mahamid; Hamza Murad; Muhammad Khatib
delete分享
delete收藏
Real-World Semaglutide Initiation Behaviours in the United States: Impact on Early Treatment Discontinuation and on 1-Year Persistence美国真实世界中的司美格鲁肽启动行为：对早期治疗中断和1年持续性的影响
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-21
delete0
PREAI
deleteL. Maria Belalcazar; Daoqi Gao; Saman Modi; Aima Meer; Yong-Fang Kuo
delete分享
delete收藏
Clinical Phenotypes Associated With Body Composition and Muscle Function in Hospitalized Japanese Patients With Type 2 Diabetes与日本住院2型糖尿病患者身体成分和肌肉功能相关的临床表型
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-21
delete0
PREAI
deleteYuichiro Iwamoto; Yui Okamoto; Hideyuki Iwamoto; Tomohiko Kimura; Ayaka Harada; Masato Kubo; Ryo Inaba; Takashi Itoh; Toshitomo Sugisaki; Haruka Takenouchi; Junpei Sanada; Masashi Shimoda; Shuhei Nakanishi; Kohei Kaku; Hideaki Kaneto
delete分享
delete收藏
Interpreting Survodutide Renoprotection in a Hyperfiltration Model在超滤模型中解释苏沃肽的肾保护作用
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-21
delete0
PREAI
deleteTing Ye
delete分享
delete收藏
Food Noise in the Era of Incretin-Based Obesity Pharmacotherapy: Current Evidence, Clinical Implications and Research Priorities基于肠促胰岛素的肥胖药物疗法时代的食物噪音：当前证据、临床意义和研究重点
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-21
delete0
PREAI
deleteDimitrios Patoulias; Djordje S. Popovic; Theocharis Koufakis
delete分享
delete收藏
Rethinking Acute Glucose Rescue in Postbariatric Hypoglycaemia重新思考减肥手术后低血糖的急性血糖救援
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-21
delete0
PREAI
deleteChristine Stier; Sonja Chiappetta; Lars Selig; Ann-Cathrin Koschker; Mohammad Kermansaravi
delete分享
delete收藏
The Smart MDI System in People With Type 1 Diabetes and High HBA1C: A Randomized Controlled Trial Demonstrating That Response to Alerts Drives Outcomes1型糖尿病和高HBA1C患者中的智能MDI系统：一项随机对照试验，证明对警报的响应驱动结果
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-21
delete0
deleteOAAI
deleteLaurent Crenier; Martin Haluzik; Marcus Lind; Pieter Gillard; Regis P. Radermecker; Angela Girelli; Jens Kroeger; Valeria Cosma; Francesco Giorgino; Charles Thivolet; Peter Adolfsson; Tobias Wiesner; Emmanuel Sonnet; Christophe de Block; Torben Biester; Helene Hanaire; Fabio di Piazza; Fabiona Hoevelaken; Renee Tillie; Tim van den Heuvel; Shannon Edd; Ohad Cohen
delete分享
delete收藏
Cardiovascular Outcomes of Insulin Degludec Versus Insulin Glargine in Trial-Eligible and Ineligible Populations: A DEVOTE-Inspired Target Trial Emulation Using the Swedish National Diabetes Register德谷胰岛素与甘精胰岛素在符合试验和不符合试验人群中的心血管结局：一项受DEVOTE试验启发的目标试验模拟，使用瑞典国家糖尿病登记数据
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-21
delete0
deleteOAAI
deleteThomas Nyström; Jens Michelsen; Henrik Imberg; Sara Hallström; Viktor Tasselius; Anna Norhammar; Max Petzold; Julia K. Mader; Pratik Choudhary; Manal K. Elzalabany; Jonathan Valabhji; Shivani Misra; Safoora Gharibzadeh; Puriya Daniel Würtz Yazdanfard; Kathrine Kold Sørensen; Christian Torp-Pedersen; Marcus Lind
delete分享
delete收藏
Nonlinear Associations of Body Muscle‐to‐Fat Ratio With Long‐Term Prognosis in MASLD体肌脂比与MASLD长期预后的非线性关联
deleteDIABETES OBESITY & METABOLISM
IF5.7
delete2026-10-20
delete0
PREAI
deleteZhe‐Kun Xiong; Ru‐Tao Lin; Yan‐Hua Lin; Xin Xin; Jian‐Dong Cao; Xiao‐Shan He; Yi‐Yang Hu; Li‐Ming Gan; Qin Feng
delete分享
delete收藏